ALSN vs DDS

Allison Transmission (ALSN) exhibits strong fundamental health with a Piotroski F-Score of 8/9, indicating robust accounting strength, though the absence of an Altman Z-Score limits distress risk assessment. The company shows exceptional profitability, including a 40.38% ROE and 27.33% operating margin, significantly outperforming sector averages. However, elevated valuation metrics, a bearish technical trend, and recent insider selling offset these strengths. While growth and cash flow fundamentals are strong, the stock trades above its Graham Number of $33.58 but below the growth-based intrinsic value of $237.18, suggesting mixed signals on valuation.

DDS exhibits exceptional financial health with a Piotroski F-Score of 8/9 and a very low Debt/Equity ratio of 0.31. However, the stock is significantly overvalued, trading at $595.20—nearly double its Graham Number ($305.57) and Intrinsic Value ($255.01). While profitability remains high with an ROE of 31.90%, the company is facing a growth stagnation with negative YoY revenue and earnings growth. The disconnect between strong fundamental health and poor valuation/growth metrics suggests a limited upside from current levels.